Haemostatix's Unattributed VC - II Round

Haemostatix raised a round of funding on June 28, 2011. Investors include Esperante.

Haemostatix is a biopharmaceutical company developing first-in-class therapies for the treatment of bleeding or 'haemostasis'. The company has pioneered a new approach to haemostasis based on targetin…

Articles about Haemostatix's Unattributed VC - II Round: